EUA
iC SARS-CoV2 Test
FDA Emergency Use Authorization · Tempus Labs, Inc. · Mar 18, 2022
Key facts
| Product | iC SARS-CoV2 Test |
|---|---|
| Company | Tempus Labs, Inc. |
| Product type | Real-time RT-PCR, Home Collection, Multiple Targets |
| Date | Mar 18, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: